Home
Departments
Research
Office of Commercialization and Industry Collaboration
Available Technologies
Toggle navigation
Menu
Home
Office of Commercialization and Industry Collaboration
Available Technologies
Categories
Office of Commercialization and Industry Collaboration
University of South Alabama
775 University Blvd. N.
Bldg. II, Ste. 150
Mobile, AL 36608-0002
Ph: (251) 460-7932
Fax: (251) 460-7955
techtransfer@southalabama.edu
Search Results - eddie+reed
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
XRCC1 as a Predictive Biomarker for Radiation Responsiveness in Patients with Prostate Cancer
OPPORTUNITY According to statistics from the American Cancer Society, prostate cancer is the second most common cancer in American men, next to skin cancer. In 2018, it is estimated that 164,690 people will be diagnosed and about 29,430 people will die of prostate cancer. About 1 man in 9 will be diagnosed with prostate cancer during his lifetime....
Inventor(s):
Eddie Reed
Category(s):
Biomarkers
,
Cancer Therapeutics
,
Screening Tests
,
All Technologies
Inhibition of Gli1 Increases Sensitivity to Cisplatin
OPPORTUNITY Platinum-based anticancer agents are among the most widely used agents in clinical oncology. Nucleotide excision repair (NER) is the pathway through which platinum–DNA damage is repaired and, ERCC1 is a useful biomarker for the NER process in human cells. Understanding the molecular and pharmacological control of NER may allow for...
Inventor(s):
Eddie Reed
,
Rajeev Samant
Category(s):
Cancer Therapeutics
,
DNA Repair Therapeutics
,
All Technologies